Advertisement

Acosta Group shares GLP-1 study insights for CPG retailers

Acosta Group shares GLP-1 study insights for CPG retailers
BY: Lily Cota

Lily Cota

JACKSONVILLE, FL — As the popularity of weight loss medications such as glucagon-1 peptide-1 (GLP-1) increases among consumers, food and beverage companies are taking actionable insights to develop personalized products and services that support lifestyle changes and long-term weight management.

Acosta Group, a collective of retail, marketing and foodservice agencies, shared the results of its proprietary GLP-1 Shopper Community study.

“Consumers’ overall high satisfaction with these medications for weight loss has been tempered primarily by concerns about side effects, weight gain if discontinued and cost,” said Kathy Risch, senior VP of shopper insights and thought leadership at Acosta Group. “It was particularly interesting to learn what lasting impacts a GLP-1 medication may have on consumers — they continue to try to maintain those healthy eating habits even as the ‘food noise’ returns.”

Advertisement

The study revealed several new insights for brands and retailers, providing opportunities to align with shifting consumer preferences.

“As a result of the study, we have identified key implications for brands and retailers regarding product prioritizations and how we can best convey product benefits to support weight loss journeys, both during and post-GLP-1 therapy,” said Jami McDermid, president of Crossmark Sales Agency, a division of Acosta Group.

Satisfaction and management

Consumers are reporting overall satisfaction with GLP-1 medications, with 84% of respondents saying they have been satisfied with their weight loss results while on the medication. Despite this, dropout rates are high.

Barriers to continued use include mild side effects such as nausea and upset stomach. Of those surveyed who experience side effects, 85% purchase products to manage them and/or purchase products to supplement nutrition gaps.

Health priorities while shopping

According to the study, nearly 80% of consumers on GLP-1 medications conduct product and health research to support their weight loss. Social media is a primary source of information for 40% of total consumers and 61% for Gen Z.

Due to the nature of the medication, many consumers are eating smaller portions, with 49% eating more healthy foods and fewer snacks. The study also reflects that those taking medications for weight loss are significantly more interested in products that offer key nutrients, such as those fortified with vitamins and protein.

Takeaways for brands and retailers

With high consumer satisfaction, companies are taking steps to reduce side effects and lower costs. This will likely lead to a reduction in the rates of discontinued use. Of the respondents who had previously been on a GLP-1, 46% said they would take the medication again to lose more weight.

Many consumers on GLP-1 medications are interested in packaged foods that support their weight loss goals and would like to see that message on the package. To meet this demand, commercial bakers can amplify digital commerce programming and advance opportunities on apps and websites in addition to boasting the nutritional benefits of their products front and center on packaging.

“As an industry, we have taken initial steps to meet this expanding market and consumer base,” McDermid said. “As use of this medication is extended and expanded for weight loss and other health advocacy, there is an opportunity to do much more, including product development, packaging, online and in-store merchandising, education and promotion.”

Advertisement

Advertisement

Related News

Advertisement

Advertisement

Advertisement

Advertisement

Popular Articles